180m Biomedical Catalyst Now Open: Register By 21st June
Tuesday 01 May 2012
The £180m Biomedical Catalyst will see the Medical Research Council and the Technology Strategy Board working together to provide responsive and effective support for the best life science opportunities arising in the UK.
Support through the Biomedical Catalyst is available to UK businesses (SMEs) and academics looking to develop innovative solutions to healthcare challenges either individually or in collaboration.
This joint programme between the MRC and TSB will offer three categories of grant - Feasibility Award, Early Stage Award and Late Stage Award - with the categories designed to support the maturation of an idea from concept to commercialisation.
Support will be available for projects arising from any sector or discipline that are aimed at addressing healthcare challenges. Example solutions may include (but are not limited to): stratified healthcare (both therapy and diagnostic components), regenerative medicine, diagnostics, eHealth and mHealth solutions, enabling medical technologies and devices.
Applicants should register their interest by the 21st June, for the first batch of grants.Further Information
Biomedical CatalystWebinar Briefing: 15th May